These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 25900064

  • 1. Design, Synthesis, and Biological Evaluation of Thiazolidine-2,4-dione Conjugates as PPAR-γ Agonists.
    Nazreen S, Alam MS, Hamid H, Shahar Yar M, Dhulap A, Alam P, Pasha MA, Bano S, Alam MM, Haider S, Kharbanda C, Ali Y, Pillai K.
    Arch Pharm (Weinheim); 2015 Jun; 348(6):421-32. PubMed ID: 25900064
    [Abstract] [Full Text] [Related]

  • 2. Synthesis, docking, in vitro and in vivo antidiabetic activity of pyrazole-based 2,4-thiazolidinedione derivatives as PPAR-γ modulators.
    Naim MJ, Alam O, Alam MJ, Shaquiquzzaman M, Alam MM, Naidu VGM.
    Arch Pharm (Weinheim); 2018 Apr; 351(3-4):e1700223. PubMed ID: 29400412
    [Abstract] [Full Text] [Related]

  • 3. Thiazolidine-2,4-diones derivatives as PPAR-γ agonists: synthesis, molecular docking, in vitro and in vivo antidiabetic activity with hepatotoxicity risk evaluation and effect on PPAR-γ gene expression.
    Nazreen S, Alam MS, Hamid H, Yar MS, Dhulap A, Alam P, Pasha MA, Bano S, Alam MM, Haider S, Kharbanda C, Ali Y, Pillai KK.
    Bioorg Med Chem Lett; 2014 Jul 15; 24(14):3034-42. PubMed ID: 24890090
    [Abstract] [Full Text] [Related]

  • 4. Design, synthesis, in silico molecular docking and biological evaluation of novel oxadiazole based thiazolidine-2,4-diones bis-heterocycles as PPAR-γ agonists.
    Nazreen S, Alam MS, Hamid H, Yar MS, Shafi S, Dhulap A, Alam P, Pasha MA, Bano S, Alam MM, Haider S, Ali Y, Kharbanda C, Pillai KK.
    Eur J Med Chem; 2014 Nov 24; 87():175-85. PubMed ID: 25255433
    [Abstract] [Full Text] [Related]

  • 5. Design, synthesis and molecular docking of thiazolidinedione based benzene sulphonamide derivatives containing pyrazole core as potential anti-diabetic agents.
    Naim MJ, Alam O, Alam MJ, Hassan MQ, Siddiqui N, Naidu VGM, Alam MI.
    Bioorg Chem; 2018 Feb 24; 76():98-112. PubMed ID: 29169079
    [Abstract] [Full Text] [Related]

  • 6. Discovery of thiazolidine-2,4-dione/biphenylcarbonitrile hybrid as dual PPAR α/γ modulator with antidiabetic effect: in vitro, in silico and in vivo approaches.
    Hidalgo-Figueroa S, Ramírez-Espinosa JJ, Estrada-Soto S, Almanza-Pérez JC, Román-Ramos R, Alarcón-Aguilar FJ, Hernández-Rosado JV, Moreno-Díaz H, Díaz-Coutiño D, Navarrete-Vázquez G.
    Chem Biol Drug Des; 2013 Apr 24; 81(4):474-83. PubMed ID: 23289972
    [Abstract] [Full Text] [Related]

  • 7. Synthesis, molecular docking, and in vivo antidiabetic evaluation of new benzylidene-2,4-thiazolidinediones as partial PPAR-γ agonists.
    Najmi A, Alam MS, Thangavel N, Taha MME, Meraya AM, Albratty M, Alhazmi HA, Ahsan W, Haque A, Azam F.
    Sci Rep; 2023 Nov 14; 13(1):19869. PubMed ID: 37963936
    [Abstract] [Full Text] [Related]

  • 8. Rational design and synthesis of some PPAR-γ agonists: Substituted benzylideneamino-benzylidene-thiazolidine-2,4-diones.
    Chhajed SS, Chaskar S, Kshirsagar SK, Haldar GM, Kar Mahapatra D.
    Comput Biol Chem; 2017 Apr 14; 67():260-265. PubMed ID: 28193552
    [Abstract] [Full Text] [Related]

  • 9. A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.
    Chang CH, McNamara LA, Wu MS, Muise ES, Tan Y, Wood HB, Meinke PT, Thompson JR, Doebber TW, Berger JP, McCann ME.
    Eur J Pharmacol; 2008 Apr 14; 584(1):192-201. PubMed ID: 18346728
    [Abstract] [Full Text] [Related]

  • 10. Design, synthesis and biological evaluation of novel 5-(imidazolyl-methyl) thiazolidinediones as antidiabetic agents.
    Shakour N, Sahebkar A, Karimi G, Paseban M, Tasbandi A, Mosaffa F, Tayarani-Najaran Z, Ghodsi R, Hadizadeh F.
    Bioorg Chem; 2021 Oct 14; 115():105162. PubMed ID: 34314919
    [Abstract] [Full Text] [Related]

  • 11. Synthesis, molecular docking and anti-diabetic evaluation of 2,4-thiazolidinedione based amide derivatives.
    Naim MJ, Alam MJ, Nawaz F, Naidu VGM, Aaghaz S, Sahu M, Siddiqui N, Alam O.
    Bioorg Chem; 2017 Aug 14; 73():24-36. PubMed ID: 28582649
    [Abstract] [Full Text] [Related]

  • 12. Novel benzenesulfonylureas containing thiophenylpyrazoline moiety as potential antidiabetic and anticancer agents.
    Kharbanda C, Alam MS, Hamid H, Javed K, Shafi S, Ali Y, Alam P, Pasha MA, Dhulap A, Bano S, Nazreen S, Haider S.
    Bioorg Med Chem Lett; 2014 Nov 15; 24(22):5298-303. PubMed ID: 25442322
    [Abstract] [Full Text] [Related]

  • 13. Pyrrolidinediones reduce the toxicity of thiazolidinediones and modify their anti-diabetic and anti-cancer properties.
    Saha S, Chan DS, Lee CY, Wong W, New LS, Chui WK, Yap CW, Chan EC, Ho HK.
    Eur J Pharmacol; 2012 Dec 15; 697(1-3):13-23. PubMed ID: 23041271
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and biological evaluation of thiazolidine-2,4-dione-pyrazole conjugates as antidiabetic, anti-inflammatory and antioxidant agents.
    Bansal G, Singh S, Monga V, Thanikachalam PV, Chawla P.
    Bioorg Chem; 2019 Nov 15; 92():103271. PubMed ID: 31536952
    [Abstract] [Full Text] [Related]

  • 15. Synthesis, characterization and biological evaluation of some novel 2,4-thiazolidinediones as potential cytotoxic, antimicrobial and antihyperglycemic agents.
    Avupati VR, Yejella RP, Akula A, Guntuku GS, Doddi BR, Vutla VR, Anagani SR, Adimulam LS, Vyricharla AK.
    Bioorg Med Chem Lett; 2012 Oct 15; 22(20):6442-50. PubMed ID: 22981328
    [Abstract] [Full Text] [Related]

  • 16. Design, synthesis, and biological evaluation of a series of alkoxy-3-indolylacetic acids as peroxisome proliferator-activated receptor γ/δ agonists.
    Gim HJ, Li H, Jeong JH, Lee SJ, Sung MK, Song MY, Park BH, Oh SJ, Ryu JH, Jeon R.
    Bioorg Med Chem; 2015 Jul 01; 23(13):3322-36. PubMed ID: 25982078
    [Abstract] [Full Text] [Related]

  • 17. Synthesis, characterization, biological evaluation and docking of coumarin coupled thiazolidinedione derivatives and its bioisosteres as PPARγ agonists.
    Shukla S, Kumar P, Das N, Moorthy NS, Shrivastava SK, Trivedi P, Srivastava RS.
    Med Chem; 2012 Sep 01; 8(5):834-45. PubMed ID: 22741802
    [Abstract] [Full Text] [Related]

  • 18. In silico designing, in vitro and in vivo evaluation of potential PPAR-γ agonists derived from aryl propionic acid scaffold.
    Kharbanda C, Alam MS, Hamid H, Ali Y, Nazreen S, Dhulap A, Alam P, Pasha MAQ.
    Bioorg Chem; 2021 Jan 01; 106():104458. PubMed ID: 33234295
    [Abstract] [Full Text] [Related]

  • 19. Antidiabetic effect of novel benzenesulfonylureas as PPAR-γ agonists and their anticancer effect.
    Kharbanda C, Alam MS, Hamid H, Javed K, Dhulap A, Bano S, Ali Y.
    Bioorg Med Chem Lett; 2015 Oct 15; 25(20):4601-5. PubMed ID: 26384286
    [Abstract] [Full Text] [Related]

  • 20. Design, synthesis and glucose uptake activity of some novel glitazones.
    Kar K, Krithika U, Mithuna, Basu P, Santhosh Kumar S, Reji A, Prashantha Kumar BR.
    Bioorg Chem; 2014 Oct 15; 56():27-33. PubMed ID: 24927033
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.